A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.

Archive ouverte

Crombez, Laurence | Aldrian-Herrada, Gudrun | Konate, Karidia | Nguyen, Quan N | Mcmaster, Gary K | Brasseur, Robert | Heitz, Frederic | Divita, Gilles

Edité par CCSD ; Cell Press -

International audience. RNA interference constitutes a powerful tool for biological studies, but has also become one of the most challenging therapeutic strategies. However, small interfering RNA (siRNA)-based strategies suffer from their poor delivery and biodistribution. Cell-penetrating peptides (CPPs) have been shown to improve the intracellular delivery of various biologically active molecules into living cells and have more recently been applied to siRNA delivery. To improve cellular uptake of siRNA into challenging cell lines, we have designed a secondary amphipathic peptide (CADY) of 20 residues combining aromatic tryptophan and cationic arginine residues. CADY adopts a helical conformation within cell membranes, thereby exposing charged residues on one side, and Trp groups that favor cellular uptake on the other. We show that CADY forms stable complexes with siRNA, thereby increasing their stability and improving their delivery into a wide variety of cell lines, including suspension and primary cell lines. CADY-mediated delivery of subnanomolar concentrations of siRNA leads to significant knockdown of the target gene at both the mRNA and protein levels. Moreover, we demonstrate that CADY is not toxic and enters cells through a mechanism which is independent of the major endosomal pathway. Given its biological properties, we propose that CADY-based technology will have a significant effect on the development of fundamental and therapeutic siRNA-based applications.

Suggestions

Du même auteur

Insight into the cellular uptake mechanism of a secondary amphipathic cell-penetrating peptide for siRNA delivery.

Archive ouverte | Konate, Karidia | CCSD

International audience. Delivery of siRNA remains a major limitation to their clinical application, and several technologies have been proposed to improve their cellular uptake. We recently described a peptide-based...

Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth.

Archive ouverte | Crombez, Laurence | CCSD

International audience. The development of short interfering RNA (siRNA), has provided great hope for therapeutic targeting of specific genes responsible for pathological disorders. However, the poor cellular uptake...

Self-assembling peptide-based nanoparticles for siRNA delivery in primary cell lines.

Archive ouverte | Deshayes, Sébastien | CCSD

International audience

Chargement des enrichissements...